Ignite Creation Date:
2024-05-05 @ 12:04 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00230178
Status:
COMPLETED
Last Update Posted:
2010-01-12
First Post:
2005-09-28
Brief Title:
Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome
Sponsor:
Sanofi
Organization:
Sanofi
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Hyperuricemia |
| Tumor Lysis Syndrome |
| Cancer |